Daftar Obat-Obatan di Indonesia
# | Nama Produk | Harga | # |
---|---|---|---|
1381 | Miratrim Suspensi 60 ml | 8.839,00 | Tiap 5 ml suspensi mengandung sulfametoxazole 200 mg dan trimetoprim 40 mg |
1382 | MIRATRIM TABLET | 39.183,00 | Sulfamethoxazole 400 mg, trimethoprim 80 mg
|
1383 | Miravon Sirup 60 ml | 7.047,00 | Tiap 5 ml sirup mengandung Bromhexine HCl 4 mg |
1384 | MIRCERA INJ PREFILLED SYRINGE 100MCG 0,3ML | 2.683.250,00 | |
1385 | MIRCERA PFS 50 MCG 0,3 ML | 1.219.660,00 | Methoxy polyethylene glycole-epoetine beta 50 mcg/0,3 ml; Methoxy polyethylene glycole-epoetine beta 75 mcg/0,3 ml; Methoxy polyethylene glycole-epoetine beta 100 mcg/0,3 ml |
1386 | MIRCERA PFS 75MCG/0,3ML | 2.012.438,00 | (belum diset) |
1387 | MIRENA IUS | 3.128.292,00 | IUS (Intra Uterine System)berupa rangka plastik berbentuk T yang dikelilingi oleh silinder pelepas hormon yang mengandung Levonorgestrel 52 mg. Mirena melepaskan hormon Levonorgestrel sebanyak 20 microgram/ hari. |
1388 | Mirzap 30 mg Tablet Salut Selaput | 555.278,00 | Tiap tablet mengandung : Mirtazapine 30 mg. |
1389 | MISOTAB TABLET | 446.775,00 | Misoprostol 200 mcg |
1390 | MISOTAB TABLET | 85.470,00 | Misoprostol 200 mcg |
1391 | MITOLIFE 60 S KAPSUL | 0,00 |
|
1392 | MITOLIFE KAPSUL | 0,00 | |
1393 | MITOMYCIN-C KYOWA VIAL 10 MG | 0,00 | Mitomisin C (kristalin) / Mitomycin C (crystalline) |
1394 | MITOMYCIN-C KYOWA VIAL 2 MG | 0,00 | Mitomisin C (kristalin) / Mitomycin C (crystalline) |
1395 | MITU BABY WIPES AS REF 60'S | 16.704,00 | (belum diset) |
1396 | MITU BABY WIPES GANTI POPOK BLUE LILY ISI 50 | 13.494,00 | |
1397 | MITU BABY WIPES GPP PINK ROSE 50 S | 13.494,00 | |
1398 | MITU BABY WIPES GPP PURPLE 50 S | 13.494,00 | (belum diset) |
1399 | MIXADIN TABLET | 27.510,00 | Tiap tablet mengandung : Dextromethorphan HBr 10 mg, Ephedrine HCl 12.5 mg, Guaifenesin 100 mg, Chlorpheniramine maleate 1 mg |
1400 | MIXAFLU SYRUP | 4.884,00 | Per 5 ml : Paracetamol 120 mg, dextromethorphan HBr 2.5 mg, chlorpheniramine maleate 1 mg, phenylpropanolamine HCl 10 mg. |